Literature DB >> 33135530

Are Disability Rates among People with Diabetes Increasing in Germany? A Decomposition Analysis of Temporal Change between 2004 and 2015.

Stefanie Sperlich1, Johannes Beller1, Jelena Epping1, Batoul Safieddine1, Juliane Tetzlaff1, Siegfried Geyer1.   

Abstract

Objectives: We investigated changes in the prevalence of disabilities among individuals with type 2 diabetes and analyzed the contribution of comorbidities on this change.
Methods: Data were drawn from the Survey of Health, Ageing, and Retirement in Europe (SHARE). We estimated predicted probabilities of impaired (instrumental) activities of daily living (IADL and ADL) by means of logistic regression. Multivariate decomposition was employed for analyzing the impact of comorbidities on changes in disability rates.
Results: Among people with diabetes, ADL difficulties rose significantly from 11.3% (2004) to 19.1% (2015), while IADL difficulties increased among younger diabetics from 11.5% to 18.3%. Decomposition analysis revealed that the parallel increase in comorbidities contributed to the rise in disabilities. Discussion: We found disability rates among people with diabetes in Germany to be increasing over time, pointing toward a growing demand of tertiary prevention for these individuals to maintain functional health and quality of life.

Entities:  

Keywords:  diabetes; disability; elderly; functioning; health status; temporal change

Year:  2020        PMID: 33135530     DOI: 10.1177/0898264320970324

Source DB:  PubMed          Journal:  J Aging Health        ISSN: 0898-2643


  2 in total

1.  Healthy life years among people with and without diabetes in Germany.

Authors:  Jens Baumert; Christin Heidemann; Lukas Reitzle; Christian Schmidt
Journal:  J Health Monit       Date:  2021-06-16

2.  Development of comorbidities in type 2 diabetes between 2005 and 2017 using German claims data.

Authors:  Batoul Safieddine; Stefanie Sperlich; Jelena Epping; Karin Lange; Siegfried Geyer
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.